Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
11 09 2020
Historique:
received: 09 07 2020
accepted: 18 08 2020
entrez: 12 9 2020
pubmed: 13 9 2020
medline: 24 9 2020
Statut: epublish

Résumé

Study of the interactions established between the viral glycoproteins and their host receptors is of critical importance for a better understanding of virus entry into cells. The novel coronavirus SARS-CoV-2 entry into host cells is mediated by its spike glycoprotein (S-glycoprotein), and the angiotensin-converting enzyme 2 (ACE2) has been identified as a cellular receptor. Here, we use atomic force microscopy to investigate the mechanisms by which the S-glycoprotein binds to the ACE2 receptor. We demonstrate, both on model surfaces and on living cells, that the receptor binding domain (RBD) serves as the binding interface within the S-glycoprotein with the ACE2 receptor and extract the kinetic and thermodynamic properties of this binding pocket. Altogether, these results provide a picture of the established interaction on living cells. Finally, we test several binding inhibitor peptides targeting the virus early attachment stages, offering new perspectives in the treatment of the SARS-CoV-2 infection.

Identifiants

pubmed: 32917884
doi: 10.1038/s41467-020-18319-6
pii: 10.1038/s41467-020-18319-6
pmc: PMC7486399
doi:

Substances chimiques

Receptors, Virus 0
Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0
Peptidyl-Dipeptidase A EC 3.4.15.1
ACE2 protein, human EC 3.4.17.23
Angiotensin-Converting Enzyme 2 EC 3.4.17.23

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4541

Commentaires et corrections

Type : ErratumIn

Références

Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270–273 (2020).
doi: 10.1038/s41586-020-2012-7
Tortorici, M. A. & Veesler, D. Structural insights into coronavirus entry. Adv. Virus Res. 105, 93–116 (2019).
doi: 10.1016/bs.aivir.2019.08.002
Yan, R. et al. Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science 367, 1444 (2020).
doi: 10.1126/science.abb2762
Gallagher, T. M. & Buchmeier, M. J. Coronavirus spike proteins in viral entry and pathogenesis. Virology 279, 371–374 (2001).
doi: 10.1006/viro.2000.0757
Simmons, G., Zmora, P., Gierer, S., Heurich, A. & Pohlmann, S. Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research. Antivir. Res. 100, 605–614 (2013).
doi: 10.1016/j.antiviral.2013.09.028
Millet, J. K. & Whittaker, G. R. Host cell proteases: critical determinants of coronavirus tropism and pathogenesis. Virus Res. 202, 120–134 (2015).
doi: 10.1016/j.virusres.2014.11.021
Alsteens, D. et al. Imaging G protein-coupled receptors while quantifying their ligand-binding free-energy landscape. Nat. Methods 12, 845–851 (2015).
doi: 10.1038/nmeth.3479
Koehler, M. et al. Glycan-mediated enhancement of reovirus receptor binding. Nat. Commun. 10, 1–14 (2019).
doi: 10.1038/s41467-019-12411-2
Newton, R. et al. Combining confocal and atomic force microscopy to quantify single-virus binding to mammalian cell surfaces. Nat. Protoc. 12, 2275 (2017).
doi: 10.1038/nprot.2017.112
Delguste, M. et al. Multivalent binding of herpesvirus to living cells is tightly regulated during infection. Sci. Adv. 4, eaat1273 (2018).
doi: 10.1126/sciadv.aat1273
Rankl, C. et al. Multiple receptors involved in human rhinovirus attachment to live cells. Proc. Natl Acad. Sci. USA 105, 17778–17783 (2008).
doi: 10.1073/pnas.0806451105
Dobrowsky, T. M., Zhou, Y., Sun, S. X., Siliciano, R. F. & Wirtz, D. Monitoring early fusion dynamics of human immunodeficiency virus type 1 at single-molecule resolution. J. Virol. 82, 7022–7033 (2008).
doi: 10.1128/JVI.00053-08
Bell, G. I. Models for the specific adhesion of cells to cells. Science 200, 618–627 (1978).
doi: 10.1126/science.347575
Evans, E., Ritchie, K. & Merkel, R. Sensitive force technique to probe molecular adhesion and structural linkages at biological interfaces. Biophys. J. 68, 2580–2587 (1995).
doi: 10.1016/S0006-3495(95)80441-8
Evans, E. & Ritchie, K. Dynamic strength of molecular adhesion bonds. Biophys. J. 72, 1541–1555 (1997).
doi: 10.1016/S0006-3495(97)78802-7
Alsteens, D. et al. Nanomechanical mapping of first binding steps of a virus to animal cells. Nat. Nanotechnol. 12, 177–183 (2017).
doi: 10.1038/nnano.2016.228
Sieben, C. et al. Influenza virus binds its host cell using multiple dynamic interactions. Proc. Natl Acad. Sci. USA 109, 13626–13631 (2012).
doi: 10.1073/pnas.1120265109
Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260–1263 (2020).
pubmed: 7164637 pmcid: 7164637
Shang, J. et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 581, 221–224 (2020).
doi: 10.1038/s41586-020-2179-y
Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426, 450–454 (2003).
doi: 10.1038/nature02145
Dimitrov, D. S. Virus entry: molecular mechanisms and biomedical applications. Nat. Rev. Microbiol. 2, 109–122 (2004).
doi: 10.1038/nrmicro817
Harcourt, J. et al. Isolation and characterization of SARS-CoV-2 from the first US COVID-19 patient. Preprint at bioRxiv https://doi.org/10.1101/2020.03.02.972935v1 (2020).
Jia, H. P. et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J. Virol. 79, 14614–14621 (2005).
doi: 10.1128/JVI.79.23.14614-14621.2005
Tortorici, M. A. et al. Structural basis for human coronavirus attachment to sialic acid receptors. Nat. Struct. Mol. Biol. 26, 481–489 (2019).
doi: 10.1038/s41594-019-0233-y
Sigrist, C. J., Bridge, A. & Le Mercier, P. A potential role for integrins in host cell entry by SARS-CoV-2. Antivir. Res. 177, 104759 (2020).
doi: 10.1016/j.antiviral.2020.104759
Prystopiuk, V. et al. Mechanical forces guiding Staphylococcus aureus cellular invasion. ACS Nano 12, 3609–3622 (2018).
doi: 10.1021/acsnano.8b00716
Zhang, H., Penninger, J. M., Li, Y., Zhong, N. & Slutsky, A. S. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 46, 586–590 (2020).
doi: 10.1007/s00134-020-05985-9
Monteil, V. et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2. Cell 181, 905–913 (2020).
doi: 10.1016/j.cell.2020.04.004
Lan, J. et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581, 215–220 (2020).
doi: 10.1038/s41586-020-2180-5
Wildling, L. et al. Linking of sensor molecules with amino groups to amino-functionalized AFM tips. Bioconj. Chem. 22, 1239–1248 (2011).
doi: 10.1021/bc200099t
Butt, H. J. & Jaschke, M. Calculation of thermal noise in atomic force microscopy. Nanotechnology 6, 1–7 (1995).
doi: 10.1088/0957-4484/6/1/001
Rankl, C. et al. Determination of the kinetic on- and off-rate of single virus-cell interactions. Methods Mol. Biol. 736, 197–210 (2011).
doi: 10.1007/978-1-61779-105-5_13
Berendsen, H. J. C., van der Spoel, D. & van Drunen, R. GROMACS: a message-passing parallel molecular dynamics implementation. Comput. Phys. Commun. 91, 43–56 (1995).
doi: 10.1016/0010-4655(95)00042-E
Lindahl, E., Hess, B. & van der Spoel, D. GROMACS 3.0: a package for molecular simulation and trajectory analysis. J. Mol. Model. 7, 306–317 (2001).
doi: 10.1007/s008940100045
Lindorff-Larsen, K. et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 78, 1950–1958 (2010).
doi: 10.1002/prot.22711
Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79, 926–935 (1983).
doi: 10.1063/1.445869
Essmann, U. et al. A smooth particle mesh Ewald method. J. Chem. Phys. 103, 8577–8593 (1995).
doi: 10.1063/1.470117
Hess, B. P-LINCS: a parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116–122 (2008).
doi: 10.1021/ct700200b
Daskhan, G. C., Pifferi, C. & Renaudet, O. Synthesis of a new series of sialylated homo-and heterovalent glycoclusters by using orthogonal ligations. ChemistryOpen 5, 477–484 (2016).
doi: 10.1002/open.201600062
Ogura, H. et al. Synthesis of 9-O-acyl-and 4-O-acetyl-sialic acids. Carbohydr. Res. 167, 77–86 (1987).
doi: 10.1016/0008-6215(87)80269-0
Fiser, A. & Šali, A. Modeller: generation and refinement of homology-based protein structure models Methods Enzymol. 374, 461–491 (2003).
doi: 10.1016/S0076-6879(03)74020-8

Auteurs

Jinsung Yang (J)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Simon J L Petitjean (SJL)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Melanie Koehler (M)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Qingrong Zhang (Q)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Andra C Dumitru (AC)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Wenzhang Chen (W)

Départment de Chimie, Laboratoire de Chimie Bio-Organique, University of Namur, Namur, Belgium.

Sylvie Derclaye (S)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

Stéphane P Vincent (SP)

Départment de Chimie, Laboratoire de Chimie Bio-Organique, University of Namur, Namur, Belgium.

Patrice Soumillion (P)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium.

David Alsteens (D)

Louvain Institute of Biomolecular Science and Technology, Université Catholique de Louvain, Louvain-la-Neuve, Belgium. david.alsteens@uclouvain.be.
Walloon Excellence in Life sciences and Biotechnology (WELBIO), 1300, Wavre, Belgium. david.alsteens@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH